D-mannoheptulose blocks how intact pancreas cell clusters respond to glucose, including their release of insulin.
See the scientific wording
In intact pancreatic islets, D-mannoheptulose suppresses the metabolic and functional responses to D-glucose, including glucose-stimulated insulin release.
Supported
Observational5 of 5 parts have evidence behind them.
Supported
5 of 5 parts have evidence behind them.
Parts of this claim
D-mannoheptulose inhibits hexose phosphorylation in homogenates.
Supported1 studyD-mannoheptulose suppresses metabolic responses to D-glucose in intact pancreatic islets.
Supported1 studyD-mannoheptulose suppresses functional responses to D-glucose in intact pancreatic islets.
Supported1 studyD-mannoheptulose suppresses glucose-stimulated insulin release in intact pancreatic islets.
Supported1 studyD-mannoheptulose does not adversely affect D-glucose catabolism in intact parotid cells.
Supported1 study
Evidence is judged against each part on its own, so a study that tests one part never counts as a verdict on the whole claim.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyIn vitro1998
The study compared intact parotid cells and pancreatic islets, showing that D-mannoheptulose suppressed metabolic and functional responses only in islets while not affecting parotid cell glucose catabolism. This differential effect supports the claim of tissue-specific suppression.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A sugar-like molecule called D-mannoheptulose blocks the first step of sugar burning. In pancreas cells, it gets inside and blocks that step, so the cells burn less sugar and release less insulin. In saliva gland cells, the molecule cannot get to the blocking site inside the cell, so sugar burning continues normally even though the molecule can block the step in a test tube.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
D-mannoheptulose blocks how intact pancreas cell clusters respond to glucose, including their release of insulin.
Mechanism
1 studyA sugar-like molecule called D-mannoheptulose blocks the first step of sugar burning. In pancreas cells, it gets inside and blocks that step, so the cells burn less sugar and release less insulin. In saliva gland cells, the molecule cannot get to the blocking site inside the cell, so sugar burning continues normally even though the molecule can block the step in a test tube.
A sugar-like molecule called D-mannoheptulose blocks the first step of sugar burning. In pancreas cells, it gets inside and blocks that step, so the cells burn less sugar and release less insulin. In saliva gland cells, the molecule cannot get to the blocking site inside the cell, so sugar burning continues normally even though the molecule can block the step in a test tube.
D-mannoheptulose enters pancreatic islet B-cells and binds to hexokinase/glucokinase, inhibiting D-glucose phosphorylation.
Inhibition of phosphorylation reduces glucose-6-phosphate formation, decreasing glycolysis and oxidative metabolism of D-glucose in islet B-cells.
Decreased glucose metabolism in islet B-cells impairs the metabolic signal that triggers glucose-stimulated insulin release, reducing insulin secretion.
In intact parotid cells, D-mannoheptulose fails to suppress D-glucose catabolism even though it inhibits hexose phosphorylation in parotid homogenates.
The intracellular transport and availability of D-mannoheptulose in intact parotid cells limit its access to hexokinase/glucokinase, preventing the antagonistic action on D-glucose metabolism.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of D-Mannoheptulose Effects on Glucose-Stimulated Insulin Release in Intact Pancreatic Islets
Systematic search of PubMed, Embase, and Web of Science for studies using intact pancreatic islets (human, rodent, or other species) exposed to D-mannoheptulose versus vehicle, measuring glucose-stimulated insulin release and metabolic responses; meta-analyze effect sizes with heterogeneity assessment.
Randomized Controlled Trial of D-Mannoheptulose Infusion on Glucose-Stimulated Insulin Secretion in Healthy Adults
Double-blind, placebo-controlled crossover RCT in healthy adults; intravenous D-mannoheptulose vs saline during hyperglycemic clamp; primary outcome glucose-stimulated insulin secretion; secondary outcomes C-peptide and glucose disposal.
Prospective Cohort Study of D-Mannoheptulose Exposure and Pancreatic Islet Function
Longitudinal cohort of adults with varying D-mannoheptulose exposure (e.g., dietary or occupational); measure fasting and stimulated insulin, C-peptide, and glucose at baseline and follow-up; adjust for confounders.
Controlled In Vitro Perifusion Study of D-Mannoheptulose on Glucose-Stimulated Insulin Release from Intact Pancreatic Islets
Isolated intact pancreatic islets from human or rodent donors; perifused with 2.8 mM then 16.7 mM glucose with or without D-mannoheptulose (dose-response); measure insulin release, NAD(P)H, ATP/ADP, and calcium flux.
Expert Opinion on D-Mannoheptulose as a Tool for Studying Glucose Metabolism in Pancreatic Islets
Structured expert panel or narrative review by islet biologists evaluating evidence for D-mannoheptulose effects on glucose-stimulated insulin release.